Peter M. Chakoutis

59 year

Health Technology

Consumer Services

Profile

Peter M.
Chakoutis served as the Chief Financial Officer at DUSA Pharmaceuticals, Inc. and as the Vice President-Finance at Harvard Apparatus Regenerative Technology, Inc. He also briefly served as the Chief Financial & Accounting Officer at Harvard Apparatus Regenerative Technology, Inc. Mr. Chakoutis holds an undergraduate degree from Norwich University and a graduate degree from Bentley Graduate School of Business.

Former positions of Peter M. Chakoutis

Companies	Position	End
HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC.	Director of Finance/CFO	2020-10-28
HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC.	Director of Finance/CFO	2020-01-16
DUSA Pharmaceuticals, Inc. DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA.	Director of Finance/CFO	2005-03-31

See the detail of Peter M. Chakoutis's experience

Training of Peter M. Chakoutis

Norwich University	Undergraduate Degree
Bentley Graduate School of Business	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Peter M. Chakoutis's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC.	Health Technology

Private companies	1
DUSA Pharmaceuticals, Inc. DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA.	Health Technology